Author Archive for webmaster

FSN Awarded Two Educational Grants

grants

Dear Fellow Neonatologists, The Florida Society of Neonatologists is pleased to announce that we have been awarded two educational grants through Ikaria. The first grant in the amount of $3000.00 was awarded for the presentation “Pulmonary Hypertension in the Preterm Infant: Early…

FSN Launches New Website

websitebuild

Dear Fellow Neonatologists, We have exciting news.  We have established a new Florida Society of Neonatologists website. MyFSN.org, our new Website has been created with the tremendous help of Michael Stoppa and Catherine Groh.   It looks great.  Please take a moment to…

Death or Neurodevelopmental Impairment at 18 to 22 Months Corrected Age in a Randomized Trial of Early Dexamethasone to Prevent Death or Chronic Lung Disease in Extremely Low Birth Weight Infants

The Journal of Pediatrics Volume 164, Issue 1 , Pages 34-39.e2, January 2014 Death or Neurodevelopmental Impairment at 18 to 22 Months Corrected Age in a Randomized Trial of Early Dexamethasone to Prevent Death or Chronic Lung Disease in Extremely…

Impact of early surfactant and inhaled nitric oxide therapies on outcomes in term/late preterm neonates with moderate hypoxic respiratory failure

J Perinatol 33: 939-943; advance online publication, September 19, 2013; doi:10.1038/jp.2013.110 Impact of early surfactant and inhaled nitric oxide therapies on outcomes in term/late preterm neonates with moderate hypoxic respiratory failure  G G Konduri, G M Sokol, K P Van Meurs, J Singer, N Ambalavanan,…

Efficacy of clonidine versus phenobarbital in reducing neonatal morphine sulfate therapy days for neonatal abstinence syndrome

J Perinatol 33: 950-953; advance online publication, August 22, 2013; doi:10.1038/jp.2013.96 Efficacy of clonidine versus phenobarbital in reducing neonatal morphine sulfate therapy days for neonatal abstinence syndrome. A prospective randomized clinical trial B Surran, P Visintainer, S Chamberlain, K Kopcza, B Shah and R Singh ABSTRACT: OBJECTIVE:…